Neelima Vidula

Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience

Seth A. Wander, Hyo S. Han, Mark L. Zangardi et al. · Journal of the National Comprehensive Cancer Network · 2021 · 82 citations

<i>FGFR1</i> Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR+) Breast Cancer

Joshua Z. Drago, Luigi Formisano, Dejan Juric et al. · Clinical Cancer Research · 2019 · 74 citations · Full text

Androgen receptor gene expression in primary breast cancer

Neelima Vidula, Christina Yau, Denise M. Wolf et al. · npj Breast Cancer · 2019 · 55 citations · Full text

Sequential use of antibody-drug conjugate after antibody-drug conjugate for patients with metastatic breast cancer: ADC after ADC (A3) study.

Rachel O. Abelman, Laura M. Spring, Geoffrey Fell et al. · Journal of Clinical Oncology · 2023 · 51 citations

Pfs Estimation, Breast Oncology, Cancer Management +20

Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer

Neelima Vidula, Christina Yau, Hope S. Rugo · Breast Cancer Research and Treatment · 2022 · 49 citations

Breast Oncology, Medicine, Pathology +6